BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38743057)

  • 1. Neem Leaf Glycoprotein disrupts exhausted CD8+ T cell-mediated cancer stem cell aggression.
    Chakravarti M; Bera S; Dhar S; Sarkar A; Choudhury PR; Ganguly N; Das J; Sultana J; Guha A; Biswas S; Das T; Hajra S; Banerjee S; Baral R; Bose A
    Mol Cancer Res; 2024 May; ():. PubMed ID: 38743057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.
    Ganguly N; Das T; Bhuniya A; Guha I; Chakravarti M; Dhar S; Sarkar A; Bera S; Dhar J; Dasgupta S; Saha A; Ghosh T; Das J; Sk UH; Banerjee S; Laskar S; Bose A; Baral R
    Cell Commun Signal; 2024 Apr; 22(1):237. PubMed ID: 38649988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
    Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
    Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8
    Bhuniya A; Guha I; Ganguly N; Saha A; Dasgupta S; Nandi P; Das A; Ghosh S; Ghosh T; Haque E; Banerjee S; Bose A; Baral R
    Front Oncol; 2020; 10():201. PubMed ID: 32211313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.
    Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R
    Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.
    Barik S; Bhuniya A; Banerjee S; Das A; Sarkar M; Paul T; Ghosh T; Ghosh S; Roy S; Pal S; Bose A; Baral R
    Int Immunopharmacol; 2013 Sep; 17(1):42-9. PubMed ID: 23747315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
    Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
    Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLGP regulates RGS5-TGFβ axis to promote pericyte-dependent vascular normalization during restricted tumor growth.
    Dasgupta S; Saha A; Ganguly N; Bhuniya A; Dhar S; Guha I; Ghosh T; Sarkar A; Ghosh S; Roy K; Das T; Banerjee S; Pal C; Baral R; Bose A
    FASEB J; 2022 May; 36(5):e22268. PubMed ID: 35363396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
    Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
    PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.
    Barik S; Banerjee S; Mallick A; Goswami KK; Roy S; Bose A; Baral R
    PLoS One; 2013; 8(6):e66501. PubMed ID: 23785504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.
    Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Biswas J; Mallick A; Bose A; Baral R
    Immunol Lett; 2016 Jul; 175():31-9. PubMed ID: 27178306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neem Leaf Glycoprotein Restrains VEGF Production by Direct Modulation of HIF1α-Linked Upstream and Downstream Cascades.
    Saha A; Nandi P; Dasgupta S; Bhuniya A; Ganguly N; Ghosh T; Guha I; Banerjee S; Baral R; Bose A
    Front Oncol; 2020; 10():260. PubMed ID: 32211322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.
    Goswami S; Bose A; Sarkar K; Roy S; Chakraborty T; Sanyal U; Baral R
    Vaccine; 2010 Feb; 28(5):1241-52. PubMed ID: 19969119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neem leaf glycoprotein generates superior tumor specific central memory CD8
    Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
    Vaccine; 2017 Aug; 35(34):4421-4429. PubMed ID: 28684164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment.
    Sarkar M; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Bera S; Chakravarti M; Dhar S; Guha I; Ganguly N; Das T; Banerjee S; Pal S; Ghosh SK; Bose A; Baral R
    Melanoma Res; 2021 Apr; 31(2):130-139. PubMed ID: 33625102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine carcinoma expressing carcinoembryonic antigen-like protein is restricted by antibody against neem leaf glycoprotein.
    Das A; Barik S; Bose A; Roy S; Biswas J; Baral R; Pal S
    Immunol Lett; 2014 Nov; 162(1 Pt A):132-9. PubMed ID: 25128841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
    Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
    J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
    Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
    Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.